HEADER TRANSFERASE 11-JUN-03 1PMQ OBSLTE 06-MAY-15 1PMQ 4Z9L TITLE THE STRUCTURE OF JNK3 IN COMPLEX WITH AN IMIDAZOLE-PYRIMIDINE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 10; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: STRESS-ACTIVATED PROTEIN KINASE JNK3, C-JUN N-TERMINAL COMPND 5 KINASE 3, MAP KINASE P49 3F12; COMPND 6 EC: 2.7.11.24; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MK10_HUMAN; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS MAP KINASE, APOPTOSIS, INHIBITION, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.SCAPIN,S.B.PATEL,J.LISNOCK,J.W.BECKER,P.V.LOGRASSO REVDAT 3 06-MAY-15 1PMQ 1 OBSLTE VERSN REVDAT 2 24-FEB-09 1PMQ 1 VERSN REVDAT 1 09-SEP-03 1PMQ 0 JRNL AUTH G.SCAPIN,S.B.PATEL,J.LISNOCK,J.W.BECKER,P.V.LOGRASSO JRNL TITL THE STRUCTURE OF JNK3 IN COMPLEX WITH SMALL MOLECULE JRNL TITL 2 INHIBITORS: STRUCTURAL BASIS FOR POTENCY AND SELECTIVITY JRNL REF CHEM.BIOL. V. 10 705 2003 JRNL REFN ISSN 1074-5521 JRNL PMID 12954329 JRNL DOI 10.1016/S1074-5521(03)00159-5 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 17.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.7 REMARK 3 NUMBER OF REFLECTIONS : 19386 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.231 REMARK 3 R VALUE (WORKING SET) : 0.228 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 953 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 20261 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.30 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1510 REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE : 0.3690 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 75 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2800 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 54 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -33.10000 REMARK 3 B22 (A**2) : 13.90000 REMARK 3 B33 (A**2) : 19.30000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.27 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.33 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.000 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.050 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.200 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.500 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.100 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.300 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : MASK REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 39.30 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1PMQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JUN-03. REMARK 100 THE RCSB ID CODE IS RCSB019431. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-JUN-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19487 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 17.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 7.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06100 REMARK 200 FOR THE DATA SET : 10.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 80.1 REMARK 200 DATA REDUNDANCY IN SHELL : 7.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.17700 REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: PDB ENTRY 1PMN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG MME 550, ETHYLENE GLYCOL, HEPES, REMARK 280 PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.47550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.76250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.47550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.76250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 38 REMARK 465 ALA A 39 REMARK 465 SER A 40 REMARK 465 LYS A 41 REMARK 465 SER A 42 REMARK 465 LYS A 43 REMARK 465 VAL A 44 REMARK 465 THR A 213 REMARK 465 ALA A 214 REMARK 465 GLY A 215 REMARK 465 THR A 216 REMARK 465 ILE A 375 REMARK 465 TYR A 376 REMARK 465 ASP A 377 REMARK 465 LYS A 378 REMARK 465 SER A 401 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 212 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 285 CG CD OE1 OE2 REMARK 470 GLN A 374 CG CD OE1 NE2 REMARK 470 GLN A 379 CG CD OE1 NE2 REMARK 470 GLU A 382 CG CD OE1 OE2 REMARK 470 ARG A 383 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 115 -4.43 -57.31 REMARK 500 ASN A 119 85.30 -150.20 REMARK 500 GLN A 140 -45.70 -134.13 REMARK 500 ARG A 188 -0.95 69.01 REMARK 500 ASP A 189 36.42 -142.87 REMARK 500 ALA A 211 171.74 64.26 REMARK 500 ASN A 243 2.66 -66.37 REMARK 500 PRO A 319 60.40 -64.77 REMARK 500 ALA A 320 90.54 -60.04 REMARK 500 ASN A 360 -34.73 -37.65 REMARK 500 TYR A 363 127.11 -32.00 REMARK 500 GLU A 382 100.76 52.05 REMARK 500 ARG A 383 123.90 178.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ANP A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 880 A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PMN RELATED DB: PDB REMARK 900 JNK3 IN COMPLEX WITH AN IMIDAZOLE-PYRIMIDINE INHIBITOR REMARK 900 RELATED ID: 1PMU RELATED DB: PDB REMARK 900 JNK3 IN COMPLEX WITH A PHENANTROLINE INHIBITOR REMARK 900 RELATED ID: 1PMV RELATED DB: PDB REMARK 900 JNK3 IN COMPLEX WITH A DIHYDROANTHRAPYRAZOLE INHIBITOR DBREF 1PMQ A 40 401 UNP P53779 MK10_HUMAN 40 401 SEQADV 1PMQ MET A 38 UNP P53779 CLONING ARTIFACT SEQADV 1PMQ ALA A 39 UNP P53779 CLONING ARTIFACT SEQRES 1 A 364 MET ALA SER LYS SER LYS VAL ASP ASN GLN PHE TYR SER SEQRES 2 A 364 VAL GLU VAL GLY ASP SER THR PHE THR VAL LEU LYS ARG SEQRES 3 A 364 TYR GLN ASN LEU LYS PRO ILE GLY SER GLY ALA GLN GLY SEQRES 4 A 364 ILE VAL CYS ALA ALA TYR ASP ALA VAL LEU ASP ARG ASN SEQRES 5 A 364 VAL ALA ILE LYS LYS LEU SER ARG PRO PHE GLN ASN GLN SEQRES 6 A 364 THR HIS ALA LYS ARG ALA TYR ARG GLU LEU VAL LEU MET SEQRES 7 A 364 LYS CYS VAL ASN HIS LYS ASN ILE ILE SER LEU LEU ASN SEQRES 8 A 364 VAL PHE THR PRO GLN LYS THR LEU GLU GLU PHE GLN ASP SEQRES 9 A 364 VAL TYR LEU VAL MET GLU LEU MET ASP ALA ASN LEU CYS SEQRES 10 A 364 GLN VAL ILE GLN MET GLU LEU ASP HIS GLU ARG MET SER SEQRES 11 A 364 TYR LEU LEU TYR GLN MET LEU CYS GLY ILE LYS HIS LEU SEQRES 12 A 364 HIS SER ALA GLY ILE ILE HIS ARG ASP LEU LYS PRO SER SEQRES 13 A 364 ASN ILE VAL VAL LYS SER ASP CYS THR LEU LYS ILE LEU SEQRES 14 A 364 ASP PHE GLY LEU ALA ARG THR ALA GLY THR SER PHE MET SEQRES 15 A 364 MET THR PRO TYR VAL VAL THR ARG TYR TYR ARG ALA PRO SEQRES 16 A 364 GLU VAL ILE LEU GLY MET GLY TYR LYS GLU ASN VAL ASP SEQRES 17 A 364 ILE TRP SER VAL GLY CYS ILE MET GLY GLU MET VAL ARG SEQRES 18 A 364 HIS LYS ILE LEU PHE PRO GLY ARG ASP TYR ILE ASP GLN SEQRES 19 A 364 TRP ASN LYS VAL ILE GLU GLN LEU GLY THR PRO CYS PRO SEQRES 20 A 364 GLU PHE MET LYS LYS LEU GLN PRO THR VAL ARG ASN TYR SEQRES 21 A 364 VAL GLU ASN ARG PRO LYS TYR ALA GLY LEU THR PHE PRO SEQRES 22 A 364 LYS LEU PHE PRO ASP SER LEU PHE PRO ALA ASP SER GLU SEQRES 23 A 364 HIS ASN LYS LEU LYS ALA SER GLN ALA ARG ASP LEU LEU SEQRES 24 A 364 SER LYS MET LEU VAL ILE ASP PRO ALA LYS ARG ILE SER SEQRES 25 A 364 VAL ASP ASP ALA LEU GLN HIS PRO TYR ILE ASN VAL TRP SEQRES 26 A 364 TYR ASP PRO ALA GLU VAL GLU ALA PRO PRO PRO GLN ILE SEQRES 27 A 364 TYR ASP LYS GLN LEU ASP GLU ARG GLU HIS THR ILE GLU SEQRES 28 A 364 GLU TRP LYS GLU LEU ILE TYR LYS GLU VAL MET ASN SER HET ANP A 502 31 HET 880 A 501 35 HETNAM ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER HETNAM 880 CYCLOHEXYL-{4-[5-(3,4-DICHLOROPHENYL)-2-PIPERIDIN-4-YL- HETNAM 2 880 3-PROPYL-3H-IMIDAZOL-4-YL]-PYRIMIDIN-2-YL}AMINE FORMUL 2 ANP C10 H17 N6 O12 P3 FORMUL 3 880 C27 H34 CL2 N6 FORMUL 4 HOH *54(H2 O) HELIX 1 1 PRO A 98 GLN A 100 5 3 HELIX 2 2 ASN A 101 MET A 115 1 15 HELIX 3 3 LEU A 153 GLN A 158 1 6 HELIX 4 4 ASP A 162 ALA A 183 1 22 HELIX 5 5 LYS A 191 SER A 193 5 3 HELIX 6 6 ALA A 231 LEU A 236 1 6 HELIX 7 7 ASN A 243 HIS A 259 1 17 HELIX 8 8 ASP A 267 GLY A 280 1 14 HELIX 9 9 CYS A 283 LYS A 289 1 7 HELIX 10 10 GLN A 291 ASN A 300 1 10 HELIX 11 11 THR A 308 PHE A 313 1 6 HELIX 12 12 PRO A 314 PHE A 318 5 5 HELIX 13 13 SER A 322 LEU A 340 1 19 HELIX 14 14 SER A 349 HIS A 356 1 8 HELIX 15 15 HIS A 356 VAL A 361 1 6 HELIX 16 16 ASP A 364 GLU A 369 1 6 HELIX 17 17 THR A 386 ASN A 400 1 15 SHEET 1 A 2 PHE A 48 VAL A 53 0 SHEET 2 A 2 SER A 56 LEU A 61 -1 O PHE A 58 N VAL A 51 SHEET 1 B 5 TYR A 64 SER A 72 0 SHEET 2 B 5 ILE A 77 ASP A 83 -1 O TYR A 82 N GLN A 65 SHEET 3 B 5 ARG A 88 SER A 96 -1 O VAL A 90 N ALA A 81 SHEET 4 B 5 ASP A 141 GLU A 147 -1 O VAL A 142 N LEU A 95 SHEET 5 B 5 ASN A 128 PHE A 130 -1 N PHE A 130 O TYR A 143 SHEET 1 C 3 ALA A 151 ASN A 152 0 SHEET 2 C 3 ILE A 195 VAL A 197 -1 O VAL A 197 N ALA A 151 SHEET 3 C 3 LEU A 203 ILE A 205 -1 O LYS A 204 N VAL A 196 SITE 1 AC1 15 GLY A 73 ALA A 74 GLN A 75 ARG A 107 SITE 2 AC1 15 LYS A 191 SER A 193 ASN A 194 TYR A 223 SITE 3 AC1 15 THR A 226 TYR A 229 GLU A 255 ILE A 261 SITE 4 AC1 15 880 A 501 HOH A 613 HOH A 649 SITE 1 AC2 19 ILE A 70 VAL A 78 ALA A 91 ILE A 92 SITE 2 AC2 19 LYS A 93 ILE A 124 LEU A 126 LEU A 144 SITE 3 AC2 19 MET A 146 LEU A 148 MET A 149 ALA A 151 SITE 4 AC2 19 ASN A 152 GLN A 155 SER A 193 ASN A 194 SITE 5 AC2 19 LEU A 206 ANP A 502 HOH A 616 CRYST1 50.951 71.525 106.000 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019627 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013981 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009434 0.00000